COMPANY

iMediSync History

Research and commercialization suggesting a new paradigm in the diagnosis and treatment of neuropsychiatric disorders

2020~

Platform Development and Commercialization.

2023
  • Entry-level iSyncWave to be released
  • Acquired ISO 13485 (2023.03)
  • Acquired FDA certification for iSyncBrain-C software medical device (2023.03)
  • Participated in CES 2023
2022
  • Selected as an excellent design product (Good Design) and won the Minister of SMEs and Startups Award
  • Won the grand prize in the bio-health sector at the 4IR Awards (4th Industrial Revolution Awards)
  • Acquired FDA 510K certification for iSyncWave as medical device (2022.08)
  • iSyncWave selected as an innovative prototype by the Public Procurement Service (2022.06)
  • iSyncBrain MCI Classifier, selected as a new medical technology for deferred evaluation (2022.05)
  • Awarded the Red Dot Design Award
  • Participated in CES 2022
2021
    • Series C Funding (6.3 million dollars)
    • iSyncWave KFDA registration as Class 2 medical device (2021.12)
    • Acquisition iSyncWave GMP cert(2021.11)
    • Designated as Innovative Product of the Year by Public Procurement Service
    • World Standards Award by Ministry of Trade, Industry, and Energy
    • Selected as 4th Industrial Revolution Outstanding Company by Ministry of Health and Welfare
    • Establishment of US Subsidiary(2021.7)
    • Designated as Innovative Product of the Year by Public Procurement Service
    • Selected as High Growth Software company by Ministry of Science and ICT
    • Participated in CES 2021. iSyncWave unveiled
2020
    • Selected as a participating company of National Dementia Overcoming Project
  • Selected as a Preliminary Unicorn Company by Ministry of SMEs and Startups
  • KFDA registration
  • · EEG analytics, iSyncBrain-C (2020.08)
  • · aMCI EEG biomarker, iSyncBrain-M1 (2020.08)
  • · HRV analytics, iSyncHeart (2020.07)
  • Designated as Big 3 Digital Healthcare Organizer by Ministry of SMEs and Startups
  • R&BD Funding(1.2 Million dollars) by Ministry of Trade, Industry, and Energy
  • Series B Funding (4.2 Million dollars)

2018~2019

Core technology development

2019
  • Selected as an Innovative Startup Project by Ministry of SMEs and Startups
  • Successful clinical trial of EEG algorithm for Screening for Amnestic Mild Cognitive Impairment
  • Mitsar EEG device KFDA registration and distributorship
  • Successful TIPS (Tech Incubator Program for Startup) graduation and Selected as Post TIPS Program Company
  • Approval of clinical trial of EEG algorithm for Screening for Amnestic Mild cognitive impairment
2018
  • Series A Funding (2.5 million dollars)

2013~2017

Founding and Team building

2017
  • Selected as Next-Generation Medical Device 100 Project by KFDA (SW platform for dementia early screening
  • Selected as TIPS Program Company by Ministry of SMEs and Startups
2016
  • Seed Funding (500 thousand dollars)
2014
  • Establishment of a Corporate research institute. (2014.04)
2013
  • Initiation of Life Span EEG Database Project jointly with National Reference EEG Data Project by Seoul National University(2018)
2012
  • Founded iMediSync, Inc.